Morgen Eric bought BIOA
February 18, 2025 · Form 4 insider transaction
Morgen Eric bought 200,000 shares of BioAge Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200,000
Price
$0.00
Total value
N/A
InsiderMorgen Eric
RoleOfficer, Director
CompanyBioAge Labs, Inc. (BIOA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2025
Filing dateFebruary 20, 2025
Shares owned after200,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.